Medeloop is a revolutionary healthcare technology company, developed to unlock treatments and widen disease comprehension. The company's technology platform harnesses regulatory-ready evidence derived from EMR/EHR, Omics, Genetics, and environmental data, to accelerate disease research and drug development.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/20/23 | $8,000,000 | Seed |
Dr. Linda Grais General Catalyst Partners  Ken Frazier Maven Ventures NV Investments Ovo Fund | undisclosed |
